Cross-modality fusion of hematology-based digital and molecular biomarkers for intelligent epidemiological screening and surveillance of hepatocellular carcinoma
{{output}}
Early detection of hepatocellular carcinoma (HCC) remains a critical challenge due to the disease's complexity and the limitations of current screening and surveillance methods, which are often invasive, costly, or lack adequate sensitivity. There is an incre... ...
